A hospital pharmacy received ampules of a commonly stocked drug contained in a pink solution. Previously the drug had always been in a clear solution. The pharmacist dispensed the drug for IV administration. The drug was contaminated and injured the patient. Assuming that the product is adulterated, explain whether the pharmacist has violated the FDCA, and if so, whether the pharmacist might face sanction by the FDA.